Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/122728
Title: Exploring N-acyl-4-azatetracyclo[5.3.2.02,6.08,10]dodec-11-enes as 11β-HSD1 inhibitors
Author: Leiva Martínez, Rosana
McBride, Andrew
Binnie, Margaret
Webster, Scott P.
Vázquez Cruz, Santiago
Keywords: Disseny de medicaments
Química farmacèutica
Enzims
Compostos policíclics
Drug design
Pharmaceutical chemistry
Enzymes
Polycyclic compounds
Issue Date: 28-Feb-2018
Publisher: MDPI
Abstract: We recently found that a cyclohexanecarboxamide derived from 4-azatetracyclo[5.3.2.02,6.08,10]dodec-11-ene displayed low nanomolar inhibition of 11β-HSD1. In continuation of our efforts to discover potent and selective 11β-HSD1 inhibitors, herein we explored several replacements for the cyclohexane ring. Some derivatives exhibited potent inhibitory activity against human 11β-HSD1, although with low selectivity over the isoenzyme 11β-HSD2, and poor microsomal stability.
Note: Reproducció del document publicat a: https://doi.org/10.3390/molecules23030536
It is part of: Molecules, 2018, vol. 23, num. 3, p. E536
URI: http://hdl.handle.net/2445/122728
Related resource: https://doi.org/10.3390/molecules23030536
ISSN: 1420-3049
Appears in Collections:Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
Articles publicats en revistes (Institut de Biomedicina (IBUB))

Files in This Item:
File Description SizeFormat 
679150.pdf2.8 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons